Uses of lipophenolic compounds
US11419841B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 12, 2018 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Nov 22, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compound of formula (I): wherein R is O—R3 or R1 and R2 are identical or different and are each independently H, (C1-C6)alkyl, —CO—(C1-C21)alkyl or —CO—(C11-C21)alkenyl group, provided that at least one of R1 or R2 is H or (C1-C6)alkyl, R3 is a —CO—(C11-C21)alkyl or —CO—(C11-C21)alkenyl group, or its pharmaceutically acceptable salts, racemates, diastereoisomers, enantiomers, or mixtures thereof, for use in prevention and/or treatment of a disease or disorder linked to an exacerbated vascular, lymphatic or mucosal permeability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.